Divarasib

Indicated For

KRAS G12C-mutated NSCLC, CRC

About This Medication

# Genentech Patient Foundation Guide: How to Get Divarasib at Low or No Cost Divarasib (GDC-6036) is an investigational KRAS G12C inhibitor developed by Genentech for treating certain cancers, such as non-small cell lung cancer with KRAS G12C mutations. The **Genentech Patient Foundation** provides free Genentech medicines like Divarasib to eligible patients without insurance or facing financial hardship.[1][8][9] ## About Divarasib Divarasib is a targeted oral therapy designed to block the KRAS G12C protein, which drives tumor growth in specific cancers. It is typically prescribed for patients whose tumors test positive for this mutation and who have progressed on prior treatments. As a Genentech product, it qualifies for support through the Genentech Patient Foundation if listed among participating medicines—contact Genentech to confirm availability.[9] Always consult your doctor for personalized medical advice, as this guide focuses on affordability, not clinical details. ## Who Qualifies for the Genentech Patient Foundation? The program helps U.S. residents prescribed a participating Genentech medicine. You may qualify if:[8] - You lack health insurance coverage. - You have insurance but face financial concerns that prevent affording your medicine. - Your insurance or employer requires PAP enrollment as a coverage condition (though some restrictions apply—see notes).[8] **Key exclusions:** Patients in Patient Assistance Diversion Programs (PADP) or those whose prescriptions are reimbursed by federal/state government programs may not qualify. The medicine must be for an FDA-approved indication.[3][10] ## Income Eligibility Breakdown Specific income thresholds (e.g., Federal Poverty Level percentages) are not publicly detailed; eligibility focuses on financial need verified case-by-case. Use the online Confirm Financial Eligibility form or call (888) 941-3331 for a personalized assessment.[8] Here's a general overview based on common PAP structures—confirm with Genentech: | Household Size | Estimated Max Income (400% FPL example, 2026)* | Notes | |---------------|-----------------------------------------------|-------| | Individual | ~$60,000 | Case-by-case review[8] | | Couple | ~$80,000 | Financial hardship key | | Family of 3 | ~$100,000 | Call for exacts | | Family of 4 | ~$120,000 | Varies by state/circumstances | *Illustrative; actual criteria depend on financial situation, not strict cutoffs. FPL adjusts annually.[8] ## Insurance Requirements The foundation targets uninsured or financially burdened patients regardless of insurance type, but government-reimbursed prescriptions (e.g., Medicare, Medicaid) are typically ineligible.[1][2][10] For insured patients: - **Commercial insurance:** Explore Genentech Access Solutions or co-pay programs first (up to $25,000 assistance for oncology meds).[2][3][7] - **Medicare:** Co-pay help via independent foundations; foundation medicine is free but not for government programs.[3][10] - Genentech Access Solutions helps navigate coverage—call (877) 436-3683.[2] ## Step-by-Step Application Process 1. **Confirm eligibility:** Visit the 'See If You Qualify' page or call (888) 941-3331 (Mon–Fri, 6 a.m.–5 p.m. PT).[1][8] 2. **Complete Patient Consent Form:** Fill online (English/Spanish) via My Patient Solutions or download.[4][5] 3. **Doctor completes Prescriber Foundation Form:** Inform your prescriber—they must submit it.[4] 4. **Submit both forms:** Fax to (833) 999-4363, text photo to 650-877-1111, or use eSubmit/online portal.[1][4][5] 5. **Wait for review:** Processed in 5 business days; your office is contacted with outcome.[4] Both forms are mandatory—no action without them. Watch the enrollment video for visuals.[4] ## Timeline and Delivery - **Processing:** 5 business days after receiving both forms.[4] - **Approval notification:** Doctor's office contacted; medicine shipped directly to you or your pharmacy. - **Delivery:** Via specialty pharmacy; details provided post-approval. Refills/reauthorization may be needed periodically.[2] ## Alternatives If Denied - **Genentech Access Solutions:** Insurance navigation, co-pay help (877-436-3683).[2] - **Co-pay programs:** For commercial insurance, up to $25,000 for oncology.[7] - **Independent foundations:** Referrals for public/commercial insurance.[3] - **Other PAPs:** Check NeedyMeds, RxAssist, or state programs. - Call Genentech for tailored options—not all apply to every medicine.[2][9] ## Disclaimer This guide is for informational purposes based on Genentech's publicly available details as of 2026. Eligibility, participating medicines (confirm Divarasib), and terms can change—verify directly with Genentech at (888) 941-3331. Not medical advice; consult your healthcare provider. Genentech reserves rights to modify programs. Free medicine limited by availability.[1][4][8]

Program information last verified: March 30, 2026